The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 16, 2024
Filed:
Mar. 14, 2023
Applicant:
Elucida Oncology, Inc., Monmouth Junction, NJ (US);
Inventors:
Kai Ma, Montgomery, NJ (US);
Aranapakam M. Venkatesan, Rego Park, NY (US);
Feng Chen, Princeton, NJ (US);
Fei Wu, Plainsboro, NJ (US);
Melik Ziya Türker, Princeton, NJ (US);
Thomas Courtney Gardinier, II, Raritan, NJ (US);
Geno J. Germano, Jr., Philadelphia, PA (US);
Gregory Paul Adams, Hatboro, PA (US);
Francis Y. F. Lee, Yardley, PA (US);
Assignee:
Elucida Oncology, Inc., Monmouth Junction, NJ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 31/4192 (2006.01); A61K 47/10 (2017.01); A61K 47/54 (2017.01); A61K 47/55 (2017.01); A61K 47/60 (2017.01); A61K 47/69 (2017.01); A61K 49/00 (2006.01); A61P 35/00 (2006.01);
U.S. Cl.
CPC ...
A61K 47/552 (2017.08); A61K 31/4192 (2013.01); A61K 47/10 (2013.01); A61K 47/545 (2017.08); A61K 47/551 (2017.08); A61K 47/558 (2017.08); A61K 47/60 (2017.08); A61K 47/6923 (2017.08); A61K 47/6929 (2017.08); A61K 49/0032 (2013.01); A61K 49/0093 (2013.01); A61P 35/00 (2018.01);
Abstract
The disclosure relates to nanoparticle drug conjugates (NDC) that comprise ultrasmall nanoparticles, folate receptor (FR) targeting ligands, and linker-drug conjugates, and methods of making and using them to treat cancer.